secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2024-04-25T23:59:59+00:00
Accession:  0001477449-24-000099
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Health Q1 revenue +3% to $646.1M; adjusted EBITDA +20% to $63.1M
------------------------------------------------------------------------

- Revenue $646.1M (+3% YoY); net loss $81.9M ($0.49 EPS) vs $69.2M loss in Q1 2023.
- Integrated Care revenue +8% to $377.1M; BetterHelp revenue -4% to $269.0M.
- Adjusted EBITDA rose 20% to $63.1M; free cash flow -$26.6M (improved from -$32.5M).
- Q2 2024 outlook: revenue $635-660M, adj. EBITDA $70-80M, net loss per share ($0.45)-($0.35).
- Full-year 2024 outlook: revenue $2,635-2,735M, adj. EBITDA $350-390M, FCF $210-240M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744924000099/0001477449-24-000099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744924000099/tdoc-20240425.htm
  HTML page:      https://secwatch.observer/filing/0001477449-24-000099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer